Table 1.
Baseline on clinical and demographic characteristics in all groups (mean and standard deviations).
| Characteristic | PSY + CHM (n = 104) |
PSY (n = 105) |
CHM (n = 111) |
Placebo (n = 104) |
|---|---|---|---|---|
| Mean age (SD), y | 49.77 (2.92) | 50.16 (2.79) | 49.5 (2.86) | 49.68 (2.93) |
| Mean body mass index (SD), kg/m2 | 22.65 (2.29) | 23.63 (3.21) | 23.17 (2.76) | 23.1 (2.81) |
| Menopausal transition (versus postmenopausal), n (%) | 66 (62.9) | 69 (66.4) | 59 (53.2) | 55 (52.9) |
| Mean Kupperman index score (SD) | 24.85 (7.55) | 24.58 (6.86) | 22.21 (5.79) | 22.38 (6.37) |
| Mean MENQOL score (SD) [12] | 267.82 (73.72) | 272.27 (64.42) | 256.52 (70.28) | 261.32 (69.93) |
| Mean vasomotor subscale score (SD) | 34.7 (9.77) | 34.39 (9.02) | 32.67 (9.02) | 31.26 (11.79) |
| Mean psychosocial subscale score (SD) | 69.6 (24.22) | 69.88 (22.51) | 61.17 (24.86) | 63.57 (25.88) |
| Mean physical subscale score (SD) | 134.42 (47.22) | 139.66 (44.33) | 135.6 (42.92) | 137.72 (40.6) |
| Mean sexual subscale score (SD) | 29.1 (15.26) | 28.33 (16.33) | 27.08 (15.21) | 28.37 (15.26) |